Subtype
Plexiform Neurofibroma
CI-CAN-00003709Explore in graph →
Non-malignant16 active trials2 evidence items
Loading cancer entity…
Subtype
CI-CAN-00003709Explore in graph →
Clinical trials
34 studies whose conditions map to this entity or one of its descendants. Status and phase are as posted on ClinicalTrials.gov. 50 studies per page.
| NCT | Title | Status | Phase | Enrollment (n) | Sponsor | Countries | Last update | Source |
|---|---|---|---|---|---|---|---|---|
| NCT06188741 | Selumetinib for the Prevention of Plexiform Neurofibroma Growth in NF Type 1(NF114) | recruiting | Phase 2 | 200 | University of Alabama at BirminghamOTHER | 1 | May 29, 2026 | clinicaltrials |
Data updated 22 days agoSource updated May 29, 2026source: clinicaltrials